Sort   by:  
 Page size 
UnknownThe analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
Not available
S-EPMC11615110 | biostudies-literature
UnknownThe global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis.
Not available
S-EPMC11743541 | biostudies-literature
GenomicsRNA Editing Genotype
Genotyping using Affymetrix SNP6.0
EGAD00010000847 | EGA
Genomicsena-DATASET-BCTL-03-07-2013-15:15:20:064-67 - samples
Transcriptome sequencing data of tumor and 10 matched normal samples of the EGAS00001000495 project
EGAD00001000627 | EGA
Genomicsena-DATASET-BCTL-18-12-2013-16:40:05:306-137 - samples
AZIN1 amplicon sequencing data of the EGAS00001000495 project.
EGAD00001000708 | EGA
Genomicsena-DATASET-BCTL-03-07-2013-15:06:18:127-64 - samples
Exome sequencing data for tumor and matched normal samples of the EGAS00001000495 project.
EGAD00001000626 | EGA
GenomicsRNA Editing in breast cancer
High-throughput sequencing screens suggest that RNA editing, which consists in the substitution of adenosine with inosine by the RNA-specific adenosine deaminase (ADAR) enzyme, occurs at several thousand positions across the human genome. Recent evidences have shown that RNA-editing could promote pr...
EGAS00001000495 | EGA
GenomicsDATA ACCESS COMMITTEE BCTL-IRIBHM
Data Access Committee EGAC00001000120
EGAC00001000120 | EGA
UnknownNeoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8.
Not available
S-EPMC10519837 | biostudies-literature
UnknownComparison of clinical characteristics of Zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico.
Not available
S-EPMC7909682 | biostudies-literature
Sort   by:  
 Page size